EFFECT OF ETHANOL EXTRACT OF PILIOSTIGMA THONNINGII LEAF ON HAEMATOLOGICAL PROFILE IN CYCLOPHOSPHAMIDE INDUCED IMMUNO SUPPRESSED RATS
Abstract
Cyclophosphamide, a widely used chemotherapeutic agent, causes immunosuppression
and hematological abnormalities. This study investigated the potential of Piliostigma
thonningii leaf extract (ELEPT) to mitigate cyclophosphamide-induced
immunosuppression and hematological toxicity in Wistar rats. Twenty-five male rats
were divided into five groups and treated for 14 days. The experimental rats were
randomly divided into five (5) groups, with five (5) animals per group and treated for a
period of fourteen (14) days. Group A: NC (normal control). Group B: immune
compromised rats (induced with cyclophosphamide) without treatment (immune
compromised control). Group C: Immune compromised rats treated with immunal
(Standard control). Group D: Immune compromised rats treated with 200 mg/kg bwt
ethanol leaf extract P.thonningiiextract (ELEPT1). Group E: immune compromised rats
with 200 mg/kg bwt ethanol leaf extract Pthonningiiextract (ELEPT?2).
Cyclophosphamide (10 mg/kg bwt) induced immunosuppression, while ELEPT (200
and 400 mg/kg bwt) significantly increased white blood cell count, lymphocytes,
neutrophils, and red blood cell parameters (RBC, Hb, PCV, MCV). The extract also
showed no significant difference in MCH and MCHC compared to the normal control.
These findings suggest that P. thonningii leaf extract possesses immunomodulatory
and hematopoietic properties, potentially mitigating cyclophosphamide-induced toxicity.
Full-Text Access Notice
In accordance with the NERD Policy on promoting peer-reviewed publication, public access to the full text of a project, thesis or dissertation is restricted for three years, allowing the author and supervisors sufficient time to pursue peer-reviewed publication.
During this period, researchers with legitimate academic or research purposes may request authorisation directly from the author to enable NERD to release the indexed full texts of the work using the form below.